- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: EGFR Mutation
Total 4265 results
-
Cancer Institute and Hospital, Chinese Academy...UnknownNon-Small Cell Lung Cancer MetastaticChina
-
Incyte CorporationWithdrawnSolid Tumors and Hematologic Malignancy | NSCLC (Non-small Cell Lung Carcinoma)United States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | EGFR Activating Mutation | Stage IV Non-Small Cell Lung Cancer AJCC v7 | ALK Gene Translocation | Stage IIIB Non-Small Cell Lung Cancer AJCC v7 | ROS1 Gene TranslocationUnited States
-
Hospital Erasto GaertnerAstraZenecaCompletedLung Neoplasms | KRAS Gene Mutation | EGFR Gene MutationBrazil
-
Betta Pharmaceuticals Co., Ltd.UnknownNon-small Cell Lung Cancer | Brain MetastasesChina
-
Astellas Pharma Global Development, Inc.Terminated
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
AZ-VUBUnknownCancers Harbouring an EGFR Mutation, (Excluding Non-squamous Non- Small Cell Lung Cancer, a Registered Indication), a HER2 Mutation or a HER3 MutationBelgium
-
University College, LondonBoehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited Kingdom
-
Yonsei UniversityUnknownCompletely Resected NSCLC With Common EGFR MutationsKorea, Republic of
-
Xinqiao Hospital of ChongqingTerminatedNon Small Cell Lung CancerChina
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungSerbia, Thailand, Poland, Romania, Egypt, Philippines, Malaysia
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.CompletedNon-small Cell Lung CancerUnited States
-
Betta Pharmaceuticals Co., Ltd.UnknownNon-Small Cell Lung Cancer | Brain Metastases
-
AstraZenecaWithdrawnNon-small Cell Lung Cancer
-
Fujian Cancer HospitalUnknown
-
Astellas Pharma IncTerminatedEGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating MutationsJapan
-
National University Hospital, SingaporeAstraZeneca; Singapore Clinical Research InstituteUnknownCarcinoma, Non-Small-Cell LungTaiwan, Hong Kong, Thailand, Singapore, Korea, Republic of
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
Guangdong Association of Clinical TrialsZhejiang Cancer Hospital; Peking University People's Hospital; Sun Yat-sen University and other collaboratorsUnknownNon-small Cell Lung CancerChina
-
First Affiliated Hospital of Guangxi Medical UniversityUnknownNon-small Cell Lung Cancer
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Sun Yat-sen UniversityUnknown
-
Hebei Medical University Fourth HospitalUnknown
-
Novartis PharmaceuticalsWithdrawnCarcinoma | Non-Small-Cell Lung Cancer
-
Betta Pharmaceuticals Co., Ltd.UnknownNon Small Cell Lung Cancer Stage IIIB | EGFR Gene Mutation | Non Small Cell Lung Cancer Stage IIIAChina
-
National Taiwan University HospitalCompleted
-
National Taiwan University HospitalCompletedNon-small Cell Lung Cancer (NSCLC)Taiwan
-
Guangdong Association of Clinical TrialsUnknown
-
Sun Yat-sen UniversityUnknown
-
Memorial Sloan Kettering Cancer CenterCompletedOligometastatic Lung AdenocarcinomaUnited States
-
Sun Yat-sen UniversityUnknown
-
Massachusetts General HospitalCompletedNon Small Cell Lung CancerUnited States
-
Boehringer IngelheimCompletedAdenocarcinoma | Carcinoma, Non-Small-Cell LungHong Kong, Canada, Korea, Republic of, Belgium, Australia, United States, Taiwan, United Kingdom, Germany, Italy, Japan, Austria, Thailand, Peru, Ireland, Russian Federation, Philippines, France, Brazil, Chile, Argentina, Hungary, M... and more
-
Fujian Cancer HospitalUnknownLung Adenocarcinoma | EGFR MutationChina
-
First People's Hospital of HangzhouCompletedNon-small Cell Lung Cancer Stage III | Non-Small-Cell Lung Cancer MetastaticChina
-
Massachusetts General HospitalBoehringer Ingelheim; University of TexasCompletedNon-small Cell Lung Cancer | EGFR MutationsUnited States
-
David M. Jackman, MDBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's HospitalCompletedNon-small Cell Lung CancerUnited States
-
Qingdao Central HospitalCompletedProgression Free SurvivalChina
-
Qingdao Central HospitalCompletedEGFR-TKI Resistant MutationChina
-
First People's Hospital of HangzhouCompletedNon-small Cell Lung Cancer Stage III | Non-Small-Cell Lung Cancer MetastaticChina
-
AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungFrance, Spain, United Kingdom, China, Canada, Taiwan
-
David M. Jackman, MDMassachusetts General Hospital; AstraZenecaCompletedNon-Small Cell Lung CancerUnited States
-
AIO-Studien-gGmbHAstraZenecaTerminatedNSCLC | Non-squamous Non-small Cell Lung Cancer Stage II | Non-squamous Non-small Cell Lung Cancer Stage IIIA | Non-squamous Non-small Cell Lung Cancer Stage IIIB | Activating EGFR MutationGermany
-
Samsung Medical CenterUnknownNon-small Cell Lung CancerKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.CompletedLung Cancer | Non Small Cell Lung CancerUnited States
-
AIO-Studien-gGmbHBoehringer IngelheimTerminatedNon-small-cell Lung Cancer With Somatic EGFR MutationsGermany
-
Lunxu LiuTerminated
-
Sichuan UniversityAstraZenecaTerminatedNon-small Cell Lung Cancer Metastatic | EGFR Activating MutationChina